CSIMarket
 


Novavax inc  (NVAX)
Other Ticker:  
 


Novavax Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NVAX Gross Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change -18.48 % -74.55 % 128.28 % -88.5 % 60.85 %
Seq. Revenue Change 55.81 % -55.94 % 424.3 % -77.35 % -51.35 %
Revenue In Millions $291.34 $186.99 $424.43 $80.95 $357.40
Gross Profit Margin 46.81 % 47.09 % 86.86 % 57.89 % 49.14 %
Gross Profit Margin Total Ranking # 1690 # 2542 # 1286 # 2299 # 2929
Gross Profit In Millions $136.37 $88.06 $368.65 $46.87 $175.63
Y / Y Gross Profit Change -22.36 % -70.65 % - -93.2 % -20.96 %
Seq. Gross Profit Change 54.86 % -76.11 % 686.62 % -73.32 % -41.45 %


Commenting fourth Quarter 2023 Gross Profit Margin
Novavax Inc has managed to improve its Revenue sequentially to $291 millions by 55.81 % faster than Gross Profit increase of 54.86 % to $136 millions, this led to contraction in Gross Profit Margin to 46.81 %, below company average.

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 42 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1690, from total ranking in previous quarter at 2542.
Learn about Gross Margin
NVAX's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 301
Overall # 1689

Gross Profit Margin Statistics
High Average Low
234.88 % 80.86 % 18.44 %
(Dec 31 2015)   (Mar 31 2012)




Other Gross Profit Margin Profitability Ratios
NVAX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NVAX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NVAX's Competitors
Gross Profit Margin Profit Margin for Novavax Inc's Suppliers
Gross Profit Margin Profit Margin for NVAX's Customers

You may also want to know
NVAX's Annual Growth Rates NVAX's Profitability Ratios NVAX's Asset Turnover Ratio NVAX's Dividend Growth
NVAX's Roe NVAX's Valuation Ratios NVAX's Financial Strength Ratios NVAX's Gross Profit Growth
NVAX's Roa NVAX's Inventory Turnover Ratio NVAX's Growth Rates NVAX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Acumen Pharmaceuticals Inc   100.00 %$ 10.791 $ 10.791 
Adaptimmune Therapeutics Plc  100.00 %$ 1.827 $ 1.827 
Armata Pharmaceuticals Inc   100.00 %$ 1.528 $ 1.528 
Anavex Life Sciences Corp   100.00 %$ 0.592 $ 0.592 
Biocardia Inc  100.00 %$ 0.013 $ 0.013 
C4 Therapeutics Inc   100.00 %$ 3.261 $ 3.261 
Coeptis Therapeutics Holdings Inc   100.00 %$ 1.388 $ 1.388 
Caribou Biosciences Inc   100.00 %$ 3.558 $ 3.558 
Curis Inc   100.00 %$ 2.696 $ 2.696 
Dbv Technologies S a   100.00 %$ 8.874 $ 8.874 
Editas Medicine Inc   100.00 %$ 60.049 $ 60.049 
Enzon Pharmaceuticals inc   100.00 %$ 0.639 $ 0.639 
Immunitybio inc   100.00 %$ 0.139 $ 0.139 
Inhibrx Inc   100.00 %$ 1.634 $ 1.634 
Century Therapeutics inc   100.00 %$ 0.268 $ 0.268 
Krystal Biotech Inc   100.00 %$ 42.143 $ 42.143 
Meiragtx Holdings Plc  100.00 %$ 2.040 $ 2.040 
Molecular Partners Ag  100.00 %$ 7.038 $ 7.038 
Pluri Inc   100.00 %$ 0.105 $ 0.105 
Sangamo Therapeutics Inc   100.00 %$ 2.042 $ 2.042 
Vaxart Inc   100.00 %$ 3.245 $ 3.245 
Voyager Therapeutics Inc   100.00 %$ 90.061 $ 90.061 
Neurocrine Biosciences Inc   98.35 %$ 506.700 $ 515.200 
Biocryst Pharmaceuticals Inc   98.33 %$ 91.844 $ 93.401 
Exelixis Inc   95.46 %$ 457.899 $ 479.652 
Argenx se  95.28 %$ 2,377.075 $ 2,494.910 
Vir Biotechnology Inc   95.25 %$ 15.989 $ 16.787 
Springworks Therapeutics Inc   92.25 %$ 5.025 $ 5.447 
Tarsus Pharmaceuticals Inc   90.70 %$ 11.860 $ 13.076 
Zeo Scientifix Inc   86.22 %$ 0.995 $ 1.154 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com